Endogenous nitric oxide mediates pancreatic exocrine secretion stimulated by secretin and cholecystokinin in rats

Pancreas

Volumn 20, Issue 4, 2000, Pages 401-407

  Jyotheeswaran, S ^a   Li, P ^a   Chang, T M ^a   Chey, W Y ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Cholecystokinin (CCK); N nitro L arginine (NNA); Nitric oxide (NO); Pancreatic secretion; Secretin; VIP

Indexed keywords

CHOLECYSTOKININ; NITRIC OXIDE; SECRETIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; EXOCRINE SECRETION; NONHUMAN; PANCREAS JUICE; PANCREAS SECRETION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; REGULATORY MECHANISM;

ANIMALS; ARGININE; BICARBONATES; CHOLECYSTOKININ; ENZYME INHIBITORS; FOOD; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; PANCREAS; PANCREATIC JUICE; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SECRETIN; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0034019387     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200005000-00011     Document Type: Article

References (30)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
2. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med 1994;120:227-37.
3. Nichols K, Staiones W, Krantis A. Nitric oxide synthase distribution in the rat intestine: a histochemical analysis. Gastroenterology 1993;105:1651-61.
4. Pique JM, Whittle BJR, Esplugues JV. The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation. Eur J Pharmacol 1989;174:293-6.
5. Lee FY, Colombato LA, Albillos A, Grossmann RJ. Administration of N-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats. Gastroenterology 1993;105:1464-70.
6. Takeuchi K, Ohuchi T, Miyake H, Niki S, Okabe S. Effects of nitric oxide synthase inhibitors on duodenal alkaline secretion in anesthetized rats. Eur J Pharmacol 1993;231:135-8.
7. Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol 1992;262:H611-5.
8. Konturek SJ, Szlachcic A, Dembinski A, Warzecha Z, Kaworek J, Stachura J. Nitric oxide in pancreatic secretion and hormoneinduced pancreatitis in rat. Int J Pancreatol 1994;15:19-28.
9. Keef KD, Du C, Ward SM, McGregor B, Sanders KM. Enteric inhibitory neural regulation of human colonic circular muscle: role of nitric oxide. Gastroenterology 1993;105:1009-16.
10. Mourelle M, Guarner F, Moncada S, Malagelada JR. The Arginine/ nitric oxide pathway modulates sphincter of Oddi motor activity in guinea pigs and rabbits. Gastroenterology 1993;105:1229-305.
11. Baker RA, Saccone GTP, Brookes SJH, Toouli J. Nitric oxide mediates nonadrenergic, noncholinergic neural relaxation in the Australian possum. Gastroenterology 1993;105:1746-53.
12. Konturek SJ, Bilski J, Konturek PK, Cieszkowski M, Pawlik W. Role of endogenous nitric oxide in the control of canine pancreatic secretion and blood flow. Gastroenterology 1993;104:896-902.
13. Li P, Zhou L, Levine RA, Chey WY. Aspirin inhibits secretagogue-stimulated and postprandial pancreatic exocrine secretion in conscious rats. Pancreas 1995;10:85-92.
14. Chang TM, Chey WY. Radioimmunoassay of secretin: a critical review and current status. Dig Dis Sci 1980;25:529-52.
15. Chang TM, Roth FL Jr, Tai HH, Chey WY. Radioimmunoassay of vasoactive intestinal polypeptide. Anal Biochem 1979;97:286-97.
16. Chang TM, Chey WY. Radioimmunoassay of cholecystokinin. Dig Dis Sci 1983;28:456-68.
17. Winer BJ. Statistical principles in experimental design. 2nd ed. New York: McGraw-Hill, 1971:149-260.
18. Schafalitzky deMuckadell OB, Fahrenkrug J, Hoist JJ, Lauritsen KB. Release of vasoactive intestinal polypeptide (VIP) by intraduodenal stimuli. Scand J Gastroenterol 1977;12:793-9.
19. Konturek SJ, Thor P, Dembinski A, Krol R. Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs. Gastroenterology 1975;68:1527-35.
20. Konturek SJ, Domschke S, Domschke W, Wunsch E, Demling L. Comparison of pancreatic responses to portal and systemic secretin and VIP in cats. Am J Physiol 1977;232:E156-8.
21. Dockray GJ. Vasoactive intestinal peptide: secretin-like action on the avian pancreas. Experientia 1973;29:1510-1.
22. Liddle RA, Green GM, Conrad CK, Williams JA. Proteins but not amino acids, carbohydrates or fats stimulate cholecystokinin secretion in the rat. Am J Physiol 1986;251:G243-8.
23. Lewis LD, Williams JA. Regulation of cholecystokinin secretion by food, hormones and neural pathways in the rat. Am J Physiol 1990;258:G512-8.
24. Li Y, Owyang C. Endogenous cholecystokinin stimulates pancreatic enzyme secretion via vagal afferent pathway in rats. Gastroenterology 1994;107:525-31.
25. Patel AG, Toyama MT, Nguyen TN, et al. Role of nitric oxide in the relationship of pancreatic blood flow and exocrine secretion in cats. Gastroenterology 1995;108:1215-20.
26. Tay SS, Burnstock G. Localization of age-related changes in NADPH-diaphorase activity in pancreatic neurons. Neuroscience 1994;61:597-602.
27. Kirchgessner AL, Liu M-T, Gershon MD. NADPH diaphorase (nitric oxide synthase)-containing nerves in the enteropancreatic innervation: sources, co-stored neuropeptides and pancreatic function. J Comp Neurol 1994;342:115-30.
28. Umehara K. Localization of NADPH-diaphorase activity and NOS immunoreactivity in the pancreas of rat and dog. Jpn J Gastroenterol 1995;92:1161-8.
29. Wrenn RW, Currie MG, Herman LE. Nitric oxide participates in the regulation of pancreatic acinar cell secretion. Life Sci 1994;55: 511-8.
30. Sho L, Miller SM, Szuszewski JH. Nitric oxide is a neuromodulator in cat pancreatic ganglia: histochemical and electrophysiological study. Neurosci Lett 1995;192:77-80.